Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transl Anim Sci ; 3(2): 749-760, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32704843

RESUMEN

Mineral intake in grazing cattle is highly variable and research evaluating behavioral aspects of intake are minimal. Development of the GrowSafe System to monitor feed intake allows researchers to record individual feeding behaviors of cattle 24 h per day. In the current experiment conducted during June and July, the GrowSafe System was utilized to evaluate intake behaviors of grazing steers during a short-term free-choice supplementation of either salt-based loose minerals (LM; n = 24; 408 ± 57 kg) or low-moisture molasses-based tub minerals (TUB; n = 24; 396 ± 64 kg). Each treatment was randomized to two of the four irrigated pastures (~5 ha each) consisting of orchard grass (Dactylis glomerat L.), red clover (Trifolium pretense L.), and smooth brome (Bromus inermis). Individual intake was evaluated over three 7-d periods: d - 7 to 0 (adaptation period; AP), d 1 to 7 (period 1; P1), and d 15 to 22 (period 2; P2) of the experiment. The LM mineral mix contained 28% salt during the AP and more salt was added at the initiation of P1 to prevent excessive mineral intake observed during the AP. The LM mineral mix contained 38% salt during P1 and P2. Daily bunk attendance was greater (P < 0.001) for LM (93%) than TUB (67%) steers for the AP. Whereas there was a treatment × period effect (P < 0.001) on daily bunk attendance across P1 (LM: 92%; TUB: 64%) and P2 (LM: 91%; TUB: 82%). Daily mineral intake (as-fed) was greater (P < 0.001) for LM (568 g) than TUB (283 g) during the AP. For P1 and P2, there were no treatment (P = 0.46) and period (P = 0.77) effects on daily mineral intake (LM, 370 g vs. TUB, 343 g), but LM (3.1 visits) had more (P < 0.001) bunk visits per day than TUB (2.0 visits). During the AP, LM (8.5 min) had a greater (P = 0.04) duration of mineral intake per day than TUB (5.6 min); whereas during P1 and P2, TUB (P1 = 8.6; P2 = 12.8 min) had a greater (P ≤ 0.05) duration of mineral intake per day than LM (P1 = 4.9; P2 = 5.7 min). In conclusion, mineral delivery method significantly affected bunk attendance, number of bunk visits per day, and time spent consuming mineral. These results provide additional evidence that mineral type and associated feeding behaviors contribute to the significant variation observed in daily mineral intake in grazing cattle.

2.
Int J Med Sci ; 11(6): 545-53, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24782643

RESUMEN

BACKGROUND: Vascular endothelial growth factor (VEGF) is essential for normal vascular growth and development during wound repair. VEGF is estrogen responsive and capable of regulating its own receptor, vascular endothelial growth factor receptor-2 (VEGFR-2). Several agricultural pesticides (e.g., methoxychlor) have estrogenic potential that can initiate inappropriate physiological responses in estrogenic-sensitive tissues following exposure in vivo. Thus, the current study was designed to determine whether the VEGFR-2-Luciferase (Luc) reporter transgenic mouse is a useful model for evaluating estrogenic tendencies of methoxychlor by monitoring wound healing via VEGFR-2-mediated gene expression using bioluminescence and real-time imaging technology. RESULTS: VEGFR-2-Luc gene activity peaked by d 7 (P<0.001) in all groups but was not different (P>0.05) between control and estrogen/methoxychlor exposed mice. CONCLUSIONS: Changes in VEGFR-2-Luc gene activity associated with the dermal wound healing process were able to be measured via photonic emission. The increase in vasculature recruitment and formation is paralleled by the increase of VEGFR-2-Luc activity with a peak on day 7. However, estrogen/methoxychlor did not significantly alter wound healing mediated VEGFR-2-Luc gene expression patterns compared to controls. This suggests that the VEGFR-2-Luc transgenic mouse wound model tested in this study may not be optimal for use as a screen for the angiogenic potential of estrogenic compounds.


Asunto(s)
Vasos Sanguíneos/crecimiento & desarrollo , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Receptor 2 de Factores de Crecimiento Endotelial Vascular/genética , Cicatrización de Heridas/genética , Animales , Vasos Sanguíneos/patología , Estrógenos/administración & dosificación , Estrógenos/metabolismo , Expresión Génica/efectos de los fármacos , Metoxicloro/administración & dosificación , Ratones , Ratones Transgénicos , Fotones , Cicatrización de Heridas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA